SOHO State of the Art Updates and Next Questions: T-Cell–Directed Immune Therapies for Multiple Myeloma: Chimeric Antigen Receptor–Modified T Cells and Bispecific T-Cell–Engaging Agents
- Resource Type
- Review Article
- Source
- In
Clinical Lymphoma, Myeloma and Leukemia September 2019 19(9):537-544 - Subject
- Language
- ISSN
- 2152-2650